2.7.7.35	(1S)-1-(1H-benzimidazol-2-yl)-N-[(1-benzofuran-3-yl)methyl]-2-methylpropan-1-amine	i.e. ZINC096223736, inhibitor identified by virtual screening; i.e. ZINC121003678, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	260677	
2.7.7.35	(2S)-2-(1H-benzimidazol-2-yl)-N-[(3-cyclopropyl-1H-pyrazol-5-yl)methyl]pyrrolidine-1-carboxamide	i.e. ZINC426746041, inhibitor identified by virtual screening	260736	
2.7.7.35	(5-amino-4-chloro-1H-pyrazol-3-yl)[(2S)-2-(5-fluoro-1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone	i.e. ZINC217844024, inhibitor identified by virtual screening, displays high amount of hydrogen bonding	260813	
2.7.7.35	2-[[(1H-benzimidazol-2-yl)methyl]sulfanyl]quinazolin-4-ol	i.e. ZINC082673, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	261213	
2.7.7.35	4-(3-methoxypropyl)-5-[[(2S)-1-(2-methyl-3H-indol-3-yl)-1-oxopropan-2-yl]sulfanyl]-2,4-dihydro-3H-1,2,4-triazol-3-one	i.e.ZINC014116837, inhibitor identified by virtual screening, displays high number of hydrophobic contacts	261415	
2.7.7.35	ADP	weak, ADP-ribose phosphorolysis	13	
2.7.7.35	ADP-ribose	competitive to phosphate	402	
2.7.7.35	Ag2+	-	1041	
2.7.7.35	AMP	kinetics	30	
2.7.7.35	AMP	-	30	
2.7.7.35	arsenate	kinetics	255	
2.7.7.35	arsenate	-	255	
2.7.7.35	ATP	kinetics	4	
2.7.7.35	ATP	-	4	
2.7.7.35	D-ribose 5-phosphate	competitive to phosphate with ADP, noncompetitive to phosphate with ADP-ribose	183	
2.7.7.35	D-ribose 5-phosphate	kinetics	183	
2.7.7.35	D-ribose 5-phosphate	-	183	
2.7.7.35	deoxyribose 5-phosphate	ADP/phosphate-exchange	1398	
2.7.7.35	IDP	weak, ADPribose phosphorolysis	444	
2.7.7.35	additional information	no inhibition by CN-, 1,10-phenanthroline, 2,2'-dipyridyl, ribose 1-phosphate, ribose 1,5-diphosphate, glucose 1-phosphate, glucose 6-phosphate; no inhibition by NADP+, EDTA, ribose	2	
2.7.7.35	additional information	no inhibition by adenosine, deoxyadenosine, 3'-AMP, CMP, CDP, UDP, NADH, NAD+, ADPglucose, UDPglucose, IAA, NEM; no inhibition by NADP+, EDTA, ribose	2	
2.7.7.35	additional information	-	2	
2.7.7.35	additional information	identification of inhibitors by large-scale molecular dynamics simulations. Eight compounds show stable binding modes in the simulations, as well as favorable drug properties. The inhibitors show hydrogen bonds to Leu126, Ala154, and Ile23	2	
2.7.7.35	N-[(1H-benzimidazol-2-yl)methyl]-3,6-dihydrocyclopenta[c]pyrazole-3-carboxamide	i.e. ZINC096232566, inhibitor identified by virtual screening	261997	
2.7.7.35	N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxamide	i.e. ZINC079784201, inhibitor identified by virtual screening	262000	
2.7.7.35	PCMB	ADP/phosphate-exchange, reversible by cysteine	78	
2.7.7.35	PCMB	ADP/phosphate-exchange and ADPribose phosphorolysis	78	
2.7.7.35	SeO42-	-	5615